MedTrace Logo

Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults With Partial Ornithine Transcarbamylase Deficiency

NCT00004498 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2015-03-25

No results posted yet for this study

Summary

OBJECTIVES:

I. Determine the safety, feasibility, and potential efficacy of intravascular adenoviral vector mediated gene transfer in the liver in adults with partial ornithine transcarbamylase deficiency.

Conditions

  • Ornithine Transcarbamylase Deficiency Disease

Interventions

GENETIC

Adenoviral Vector-Mediated Gene Transfer

Sponsors & Collaborators

Principal Investigators

  • Steven E. Raper · University of Pennsylvania

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-07-31
Completion
2000-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004498 on ClinicalTrials.gov